GENEVA, Aug. 17 -- TELIGENE LTD (218 Xinghu St., BioBay A4 Building, 416, Suzhou Industrial Park,Suzhou, Jiangsu 215123), 苏州韬略生物科技股份有限公司 (中国江苏省苏州市苏州工业园区星湖街218号生物纳米园A4楼416单元) filed a patent application (PCT/CN2025/075840) for "TRISUBSTITUTED QUINAZOLINE DERIVATIVE, ACID ADDITION SALT THEREOF, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF" on Feb 05, 2025. With publication no. WO/2025/167927, the details related to the patent application was published on Aug 14, 2025...